This federal contract award is for the delivery of Omnipod Dash Pods (Gen 4), a medical device used for the management of diabetes. The contract, valued at $5,347.17, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company.
The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, through its extensive supply chain network, is able to efficiently fulfill government contracts for critical medical products and pharmaceuticals.
Generated 8/23/24, 4:29 PM